Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Horizon Therapeutics Public Ltd Co changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 615 | 8 | 528 | −79 |
| Shares | 207.9M | 20.8K | 209.9M | +1.99M (+1.0%) |
| Value | $16.5B | $1.67M | $13.0B | −$3.51B (−21.3%) |
8 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (59)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (138)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q2 2022 and filed for Q3 2022 without it.
Showing the largest 100 of 138 by value.
Not filed for Q3 2022 yet (8)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Dixon Hubard Feinour & Brown Inc | 8,986 | $717.0K |
| Brewin Dolphin Wealth Management Ltd | 4,475 | $357.0K |
| HighPoint Advisor Group LLC | 3,538 | $292.0K |
| Private Capital Group, LLC | 2,502 | $200.0K |
| Exane Derivatives | 1,017 | $81.1K |
| Fieldpoint Private Securities, LLC | 165 | $13.0K |
| Enterprise Trust & Investment Co | 68 | $5.00K |
| Urban Wealth Management, LLC | 18 | $1.00K |